1.3500
-0.1700
(-11.18%)
At close: 12:03:27 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-137,302
-137,302
-63,826
-53,204
-63,806
Investing Cash Flow
-61,794
-61,794
-51,355
-161,985
-26,939
Financing Cash Flow
64,734
64,734
-13,715
622,905
158,577
End Cash Position
220,536
220,536
356,778
487,840
80,863
Capital Expenditure
-27,290
-27,290
-27,795
-30,817
-26,472
Issuance of Capital Stock
71,597
71,597
3,751
642,144
163,955
Repayment of Debt
--
--
-9,500
--
--
Free Cash Flow
-164,592
-164,592
-91,621
-84,021
-90,278
12/31/2020 - 10/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1AE.F argenx SE
600.20
+1.73%
GNRO.PA GeNeuro SA
0.0990
0.00%
KRBP Kiromic BioPharma, Inc.
1.5000
0.00%
NWRN.SW Newron Pharmaceuticals S.p.A.
9.72
-1.82%
GNFT.PA Genfit S.A.
3.4850
0.00%
DNTH Dianthus Therapeutics, Inc.
19.62
-9.17%
BION.SW BB Biotech AG Ord
36.90
-0.27%
IVA Inventiva S.A.
2.9600
-3.58%
RLF.SW Relief Therapeutics Holding SA
3.0700
-2.54%
BVNRY Bavarian Nordic A/S
7.68
-1.16%